Glutathione Injection vs Oral vs IV

Glutathione injection vs oral vs IV at a glance

Glutathione is a tripeptide the body makes. As a product it reaches consumers as a compounded injectable vial for intramuscular or subcutaneous use, as an intravenous infusion mixed for a clinic visit, or as an oral capsule, liposomal liquid, or lozenge sold as a dietary supplement. The molecule is the same; the regulatory path, the maker, and the purchase channel are not.

The table separates the three by the facts a buyer can check. Regulatory statements come from FDA's compounding and dietary-supplement pages, and the harm records come from FDA alerts and recall notices.

None of the three is an FDA-approved glutathione drug

FDA states that compounded drugs are not FDA-approved and that the agency does not verify their safety, effectiveness, or quality before they are marketed. Glutathione injections and IV infusions fall in that category. Glutathione appears in category 1, bulk drug substances under evaluation, on FDA's list of substances nominated for the 503A bulks list, updated May 14, 2026, and on the 503B list updated March 21, 2025. FDA says it does not intend to act against compounders using a category 1 substance if the guidance conditions are met, which is the basis on which pharmacies compound it.

Oral glutathione is regulated as a dietary supplement. FDA says it is not authorized to approve dietary supplements for safety and effectiveness before they are marketed, and the manufacturer is responsible for the product. That is a lighter standard than a drug approval and a different one from compounding.

Who makes each form and who checks it

A compounded glutathione injection comes from a 503A pharmacy, a state-licensed pharmacy that compounds for individual prescriptions under its state board of pharmacy, or from a 503B outsourcing facility that registers with FDA and follows current good manufacturing practice. IV glutathione is prepared the same way, or by a clinic that mixes a bag for infusion. The quality of a sterile product depends on the grade of the raw glutathione and on the compounding process, and FDA's inspections regularly find insanitary conditions at compounding facilities.

FDA's August 27, 2026 alert describes exactly how that fails. At least 30 patients had adverse events after intravenous glutathione compounded by different pharmacies that all bought lot 229536 from Medisca, labeled as dietary supplement grade, which FDA says is not an appropriate ingredient for injectable drugs. Two Texas pharmacies recalled their injectable glutathione for elevated endotoxin. Optimal Balance Pharmacy in Houston recalled its 200 mg/mL, 30 mL multi-dose vials, lot LG342009076, shipped to patients in 14 states, after reports of fever, chills, severe headache, nausea, vomiting, pain, and allergic-type reactions. The same failure mode appeared in 2019, when seven patients reacted to IV L-glutathione made from a dietary ingredient repackaged by Letco Medical, with endotoxin results up to five times the limit.

Fever, chills, muscle pain, headache, nausea, low blood pressure, or shock-like symptoms after a glutathione injection or infusion are the endotoxin pattern FDA describes. Seek urgent care and report the product through MedWatch.

How each form is dosed, stored, and given

A telehealth glutathione injection is usually a multi-dose vial at a pharmacy-specific concentration, drawn up with a syringe on a schedule the prescriber writes. The recalled 2026 products were 200 mg/mL vials of 30 mL. Storage and in-use limits come from the pharmacy label, and a multi-dose sterile vial should be discarded on the date the label states. Telehealth Ledger does not publish dose, syringe-unit, or reconstitution instructions for compounded products.

IV glutathione is infused in a clinic over a visit, alone or mixed with other ingredients, which is how the 2026 and 2019 adverse events occurred. Oral glutathione is taken by mouth at the dose printed on the supplement label; it needs no prescription, no refrigeration in most products, and no sterility, which is why the compounding alerts do not reach it. Whether any form produces a measurable health effect is a separate question that the human-evidence guide linked below addresses.

How each form is bought and what it costs

Compounded glutathione injections are sold almost entirely through telehealth programs that bundle a clinician consultation, a prescription to a partner pharmacy, and shipping. IV glutathione is bought as a clinic service, priced per infusion or per package, often at a medical spa or wellness clinic. Oral glutathione is bought at retail without a prescription. Because no manufacturer holds an approved product, there is no list price for any form and no manufacturer savings program.

The catalog module below shows published telehealth prices for compounded glutathione injections with their price basis and verification date. It does not include clinic infusion prices or retail supplement prices, which vary by location and product and are not tracked here.

What to ask a telehealth provider or clinic

These questions target the exact failure FDA has documented: the grade of the raw ingredient and the sterility of the finished product.

• Which pharmacy compounds the glutathione, is it a 503A pharmacy or a 503B outsourcing facility, and in which state is it licensed?
• Was the glutathione ingredient pharmaceutical grade, and can the pharmacy confirm it was not dietary-supplement-grade material such as the Medisca lot named by FDA?
• Does the pharmacy test each lot for bacterial endotoxin and sterility, and will it share the certificate of analysis?
• What is the concentration, the discard date after first use, and the written injection instructions?
• What does the price include, and what is the continuing monthly price after any introductory offer?
• What should I do and whom do I call if I develop fever or chills after a dose?